I-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4.
Ontology highlight
ABSTRACT: CXCR4 is a G protein-coupled receptor with excellent potential as a therapeutic target for a range of clinical conditions, including stem cell mobilization, cancer prognosis and treatment, fibrosis therapy, and HIV infection. We report here the development of a fully human single-domain antibody-like scaffold termed an "i-body," the engineering of which produces an i-body library possessing a long complementarity determining region binding loop, and the isolation and characterization of a panel of i-bodies with activity against human CXCR4. The CXCR4-specific i-bodies show antagonistic activity in a range of in vitro and in vivo assays, including inhibition of HIV infection, cell migration, and leukocyte recruitment but, importantly, not the mobilization of hematopoietic stem cells. Epitop
SUBMITTER: Griffiths K
PROVIDER: S-EPMC4933451 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA